Correlation Analysis
Johnson & Johnson vs Vertex Pharmaceuticals Inc
JNJ vs VRTX
+0.062
Weak positive
When one moves up, the other tends to follow.
Johnson & Johnson
↗JNJ
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Market cap 580.4B
Vertex Pharmaceuticals Inc
↗VRTX
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Market cap 110.5B · 6,400 employees
Time Series
Relative Performance
Who Moves First
in sync
JNJ and VRTX tend to move at the same time.
After testing 13 timing shifts, the strongest relationship was +0.062 (they moved in the same direction).
Do They Crash Together?
Correlation by Market Regime
How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.
Both Rising
-0.188
13 periods · Return correlation when both series rose
Both Falling
+0.773
9 periods · Return correlation when both series fell
Diverging
-0.745
13 periods · Return correlation when series moved apart
R-Squared
0.4%
Share of variance in one series explained by the other.
Trend Agreement
62.2%
How often both series moved in the same direction period-to-period.
Overlap Quality
1,254
Deep shared window — 1,254 usable pairs.
Significance
p < 0.05
95% CI: [0.007, 0.117]
Scatter
XY Regression
Pipeline
Data quality details
Pipeline
Data quality details
Pipeline Summary
1,254 paired data points survived the daily window.
Raw input
1,254
1,254
Normalized
1,254
1,254
Prepared
1,254
1,254
Aligned
1,254
1,254
Invalid removed
0
A: 0 / B: 0
Duplicates removed
0
A: 0 / B: 0
Alignment drops
0
A: 0 / B: 0
Series A
Johnson & Johnson
JNJ
Market cap 580.4B
Stock · 1,254 raw → 1,254 prepared
Series B
Vertex Pharmaceuticals Inc
VRTX
Market cap 110.5B · 6,400 employees
Stock · 1,254 raw → 1,254 prepared
Sign agreement
100.0%
How often both values share the same sign.
Zero crossings
15
Estimated crossover points between normalized spreads.
Slope
0.3167
Linear regression slope.
Intercept
301.7953
Linear regression intercept.
Related Extremes
Highest and Lowest Correlated
JNJ
Johnson & Johnson
Highest
+0.943
Sandisk Corporation Common Stock
SNDK · 281 data points
Lowest
-0.621
Kimberly-Clark Corp.
KMB · 1,254 data points
VRTX
Vertex Pharmaceuticals Inc
Highest
+0.939
Eli Lilly & Co.
LLY · 1,254 data points
Lowest
+0.214
Tesla, Inc. Common Stock
TSLA · 1,254 data points
Saved 4 hours ago · ID: stock-jnj-vs-stock-vrtx-daily